このエントリーをはてなブックマークに追加
ID 52930
Sort Key
3
Title Alternative
The 2013 Incentive Award of the Okayama Medical Association in Cardiovascular and Pulmonary Research (2013 Sunada Prize)
FullText URL
Thumnail 126_195.pdf 379 KB
Author
Abstract
受賞対象論文: Akagi S, Nakamura K, Matsubara H, Kusano KF, Kataoka N, Oto T, Miyaji K, Miura A, Ogawa A, Yoshida M, Ueda-Ishibashi H, Yutani C, Ito H:Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Int J Cardiol (2013) 165, 499-505.
Note
平成25年度岡山医学会賞紹介記事 (The 2013 Okayama Medical Association Award)
Publication Title
岡山医学会雑誌
Published Date
2014-12-01
Volume
volume126
Issue
issue3
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
195
End Page
197
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2014 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma
References
1) McLaughlin VV, Shillington A, Rich S : Survival in primary pulmonary hypertension : The impact of epoprostenol therapy. Circulation (2002) 106, 1477-1482.
2) Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G : Long-term intravenous epoprostenol infusion in primary pulmonary hypertension : Prognostic factors and survival. J Am Coll Cardiol (2002) 40, 780-788.
3) McLaughlin VV, Genthner DE, Panella MM, Rich S : Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med (1998) 338, 273-277.
4) Akagi S, Nakamura K, Miyaji K, Ogawa A, Kusano KF, Ito H, Matsubara H : Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension. Circ J (2010) 741, 2200-2205.